NZ515765A - Method of protecting lactobacillus johnsonii La1 from stress or shock - Google Patents

Method of protecting lactobacillus johnsonii La1 from stress or shock

Info

Publication number
NZ515765A
NZ515765A NZ515765A NZ51576500A NZ515765A NZ 515765 A NZ515765 A NZ 515765A NZ 515765 A NZ515765 A NZ 515765A NZ 51576500 A NZ51576500 A NZ 51576500A NZ 515765 A NZ515765 A NZ 515765A
Authority
NZ
New Zealand
Prior art keywords
stress
cells
lethal
shock
lactobacillus johnsonii
Prior art date
Application number
NZ515765A
Other languages
English (en)
Inventor
Gudrun Schmidt
Ralf Zink
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NZ515765A publication Critical patent/NZ515765A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
NZ515765A 1999-06-11 2000-06-09 Method of protecting lactobacillus johnsonii La1 from stress or shock NZ515765A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13894699P 1999-06-11 1999-06-11
PCT/EP2000/005403 WO2000077186A2 (fr) 1999-06-11 2000-06-09 Protection bacterienne

Publications (1)

Publication Number Publication Date
NZ515765A true NZ515765A (en) 2003-07-25

Family

ID=22484378

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ515765A NZ515765A (en) 1999-06-11 2000-06-09 Method of protecting lactobacillus johnsonii La1 from stress or shock

Country Status (8)

Country Link
EP (1) EP1190038A2 (fr)
JP (1) JP3774146B2 (fr)
CN (1) CN1330748C (fr)
AU (1) AU771519B2 (fr)
BR (1) BR0011742A (fr)
NZ (1) NZ515765A (fr)
WO (1) WO2000077186A2 (fr)
ZA (1) ZA200109670B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839855B1 (fr) * 2002-05-27 2005-09-30 Biosaveurs Procede de preparation d'une flore d'affinage comportant une etape de fragilisation cellulaire
EP2053122A1 (fr) 2007-10-23 2009-04-29 Nestec S.A. Bifidobactérie tolérante au stress
JP6216507B2 (ja) * 2012-12-20 2017-10-18 雪印メグミルク株式会社 酸化ストレス耐性が向上した微生物およびその製造方法
CN103275921B (zh) * 2013-05-16 2015-04-15 江南大学 一种提高乳杆菌耐胆盐能力的方法

Also Published As

Publication number Publication date
BR0011742A (pt) 2002-03-19
AU6262900A (en) 2001-01-02
CN1378591A (zh) 2002-11-06
AU771519B2 (en) 2004-03-25
JP2003502037A (ja) 2003-01-21
ZA200109670B (en) 2003-02-24
WO2000077186A2 (fr) 2000-12-21
EP1190038A2 (fr) 2002-03-27
CN1330748C (zh) 2007-08-08
JP3774146B2 (ja) 2006-05-10
WO2000077186A3 (fr) 2001-06-28

Similar Documents

Publication Publication Date Title
Schmidt et al. Basic features of the stress response in three species of bifidobacteria: B. longum, B. adolescentis, and B. breve
EP2018441B1 (fr) Micro-organismes marqués et procédés de marquage
Achemchem et al. Enterococcus faecium F58, a bacteriocinogenic strain naturally occurring in Jben, a soft, farmhouse goat's cheese made in Morocco
Gautam et al. Purification and characterization of bacteriocin produced by Lactobacillus brevis UN isolated from Dhulliachar: a traditional food product of north east India
TUNCER et al. Occurrence of enterocin genes, virulence factors, and antibiotic resistance in 3 bacteriocin-producer Enterococcus faecium strains isolated from Turkish tulum cheese
Bu et al. Analyses of plantaricin Q7 synthesis by Lactobacillus plantarum Q7 based on comparative transcriptomics
Tolinački et al. Characterization of the bacteriocin-producing strain Lactobacillus paracasei subsp. paracasei BGUB9
AU771519B2 (en) Bacterial protection
Aspholm et al. Biochemical and mutational analysis of spore cortex-lytic enzymes in the food spoiler Bacillus licheniformis
US6939705B1 (en) Method of protecting L. johnsonii La1 against stress
Suardana et al. Probiotic potency and molecular identification of lactic acid bacteria isolated from Bali cattle’s colon, Indonesia
Mirhadizadi et al. Molecular isolation, probiotic property, and bacteriocin production of Enterococcus faecium (TM81) and Lactobacillus curvatus (TM51) with anti-listerial activity in native dairy products of Iran
US20240360429A1 (en) Compositions and methods for controlling adaptive immunity in bacteria
AU2002328340A1 (en) Nucleic acid free ghost preparations
WO2003006630A2 (fr) Preparations fantomes exemptes d'acides nucleiques
KR102405050B1 (ko) 마이크로바이옴 화장품 시료 내의 더마바이오틱스 분석 방법
Carlos et al. Isolation of a Lactobacillus strain from aguamiel and preliminary characterization of its antimicrobial components
KR100574069B1 (ko) 리스테리아 속 균종을 검출하는 방법 및 검출키트
Ibegwam et al. A Study on the Screening for Lactic Acid Bacteria from Fura Da Nono with Antibacterial and Bio Preservative Properties
CN118480104B (zh) 一种乳酸菌细菌素及其应用
Dasen Molecular identification and applied genetics of propionibacteria
Van Nguyen et al. Selection and characterization of probiotic Enterococcus strains isolated from Vietnamese fermented foods
Huyghe Selection of reference genes for gene expression studies in lactic acid bacteria
AL-Rikabi et al. Purification of the biologically active peptide from a new strain of Lactobacillus delbrueckii JKD5 isolated from local yogurt and study of its antimicrobial properties against some microorganisms
Ihum et al. Antibacterial Activity of Bacteriocin-Like Inhibitory Substance Produced by Lactic Acid Bacteria against Staphylococcus aureus and E. coli of Sesame Seeds

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)